MedPath

Safety & Feasibility of Functional Electrical Stimulation for The Treatment of Premature Ejaculation

Not Applicable
Conditions
Premature Ejaculation
Interventions
Device: Functional TENS stimulation
Device: Non-Functional TENS stimulation
Registration Number
NCT03177226
Lead Sponsor
Virility Medical Ltd.
Brief Summary

Prospective, non-randomized, controlled, single-center study, to evaluate the efficacy of applied nominal electrical stimulation parameters given to premature ejaculation (PE) patients in order to prolong the ejaculatory latency time which will eventually increase the quality of their sexual life.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • Good general health
  • Clinical history of premature ejaculation
  • Familiar with self- stimulation
  • Ability to follow study instructions and complete study assessment tools
  • Washout period of two weeks
Exclusion Criteria
  • History of cardio-vascular disorders
  • Any type of implanted pacemaker/defibrillator
  • Hypertension
  • Diabetes Mellitus
  • Local dermatological disease
  • Local skin irritation/ lesions
  • Any neurological disorder
  • Any psychiatric disease and/or any psychiatric medications
  • Any neoplastic disease in the past two years

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Functional TENS stimulationFunctional TENS stimulationShort stimulation to identifying Sensory Threshold and Motor Threshold, followed by continuous functional electrical stimulation, throughout the entire self-stimulation phase \[from full erection to ejaculation\]
Non-stimulation treatmentNon-Functional TENS stimulationShort stimulation to identifying Sensory Threshold and Motor Threshold, followed by continuous non-functional electrical stimulation, throughout the entire self-stimulation phase \[from full erection to ejaculation\]
Primary Outcome Measures
NameTimeMethod
Incidence of Treatment-Emergent Adverse EventsProcedure day

All Self reported safety events (e.g. discomfort, pain, local irritation, local heat, noticeable changes in urination or bowl activity or any other complaint)

Change in ejaculation latency timeProcedure day

The difference between patient ejaculation latency time under perineal functional electrical stimulation during self-stimulation, and latency time during self-stimulation while no electrical stimulation is applied

Secondary Outcome Measures
NameTimeMethod
Incidence of post-treatment Adverse Events72 hours

Post treatment safety evaluation completed by subjects (using safety questionnaire)

Trial Locations

Locations (1)

Rambam Health Care Campus

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath